ProShare Advisors LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$292,604
-57.4%
7,692
+2.1%
0.00%
-50.0%
Q2 2023$686,439
-45.2%
7,535
-60.3%
0.00%
-50.0%
Q1 2023$1,251,525
+6.9%
18,974
-16.2%
0.00%0.0%
Q4 2022$1,170,559
-18.7%
22,637
+7.4%
0.00%
-33.3%
Q3 2022$1,439,000
+72.1%
21,068
+13.8%
0.01%
+100.0%
Q2 2022$836,000
-30.7%
18,510
-22.0%
0.00%0.0%
Q1 2022$1,207,000
-12.3%
23,745
-18.5%
0.00%0.0%
Q4 2021$1,377,000
+55.4%
29,151
+8.4%
0.00%
+50.0%
Q3 2021$886,000
-55.2%
26,894
-14.1%
0.00%
-66.7%
Q2 2021$1,979,000
+69.7%
31,313
+15.2%
0.01%
+50.0%
Q1 2021$1,166,000
-18.5%
27,179
+8.7%
0.00%
-20.0%
Q4 2020$1,430,000
+142.4%
24,993
+27.9%
0.01%
+66.7%
Q3 2020$590,000
-10.7%
19,547
-3.4%
0.00%
-25.0%
Q2 2020$661,000
+80.6%
20,227
+48.1%
0.00%
+33.3%
Q1 2020$366,000
-41.5%
13,656
-33.2%
0.00%0.0%
Q4 2019$626,000
+14.2%
20,436
-10.2%
0.00%0.0%
Q3 2019$548,000
-3.0%
22,749
+2.1%
0.00%0.0%
Q2 2019$565,000
+26.1%
22,278
-3.1%
0.00%0.0%
Q1 2019$448,000
+48.3%
22,995
+0.6%
0.00%
+50.0%
Q4 2018$302,00022,8680.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders